BioPharma Deals: The Survival Series is a new kind of event, a high-impact conference built for companies navigating today’s funding drought by partnering smarter, earlier, and more creatively. We bring together biotech, pharma, investors, and advisors to explore practical pathways to collaboration when traditional funding sources have slowed.

Forget generic discussions. This is a conference for those on the front lines, dealmakers, BD&L teams, and executives, solving real problems with real partnerships.

If you’re seeking licensing, M&A, risk-sharing alliances, or alternative routes to capital and commercialisation, this is where you meet the people and ideas that can move you forward.